The higher vitamin D level in IBD children (22.6 ng/mL vs. 17.45 ng/mL in not treated group; p > 0.05) treated with biological drugs, such as infiximab, can be explained by known the tumor necrosis factor (TNF alpha) effect on bone metabolism. Here, TNF is linked to inflammatory bowel disease.